VA
INSM icon

Vident Advisory’s Insmed INSM Stock Holding History

Vident Advisory’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.6M Buy
9,808
+4,794
+96% +$737K 0.01% 691
2025
Q4 		$873K Sell
5,014
-544
-10% -$99.3K 0.01% 874
2025
Q3 		$800K Sell
5,558
-121
-2% -$14.8K 0.01% 938
2025
Q2 		$572K Sell
5,679
-1,176
-17% -$89.9K 0.01% 970
2025
Q1 		$523K Buy
6,855
+1,918
+39% +$147K 0.01% 1008
2024
Q4 		$341K Buy
4,937
+1,312
+36% +$94.5K 0.01% 1123
2024
Q3 		$265K Buy
+3,625
New +$268K 0.01% 1183

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vident Advisory's INSM Position: Q1 2026 in Review

Vident Advisory increased its Insmed (INSM) stake by 96% in Q1 2026, buying an estimated $737K and bringing the position to 9,808 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #691.

Vident Advisory first reported a position in INSM in Q3 2024 and has held it in 7 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Vident Advisory held 9,808 shares of Insmed worth $1.6M as of Q1 2026.
  • Vident Advisory bought 4,794 Insmed shares in Q1 2026, an estimated $737K.
  • Insmed made up 0.01% of Vident Advisory's portfolio in Q1 2026, its #691 holding.
  • Vident Advisory first reported a position in Insmed in Q3 2024 and has held it in 7 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.